Literature DB >> 26983891

MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.

Young Ran Park1, Soo Teik Lee1, Se Lim Kim1, Yu Chuan Liu1, Min Ro Lee2, Ja Hyun Shin3, Seung Young Seo1, Seong Hun Kim1, In Hee Kim1, Seung Ok Lee1, Sang Wook Kim1.   

Abstract

Transmembrane-4-L6 family 1 (TM4SF1) is upregulated in colorectal carcinoma (CRC). However, the mechanism leading to inhibition of the TM4SF1 is not known. In the present study, we investigated the regulation of TM4SF1 and function of microRNAs (miRNAs) in CRC invasion and metastasis. We analyzed 60 colon cancers and paired normal specimens for TM4SF1 and miRNA-9 (miR-9) expression using quantitative real-time PCR. A bioinformatics analysis identified a putative miR-9 binding site within the 3'-UTR of TM4SF1. We also found that TM4SF1 was upregulated in CRC tissues and CRC cell lines. The expression of TM4SF1 was positively correlated with clinical advanced stage and lymph node metastasis. Moreover, a luciferase assay revealed that miR-9 directly targeted 3'-UTR-TM4SF1. Overexpression of miR-9 inhibited expression of TM4SF1 mRNA and protein, wound healing, transwell migration and invasion of SW480 cells, whereas, overexpression of anti-miR-9 and siRNA-TM4SF1 inversely regulated the TM4SF1 mRNA and protein level in HCT116 cells. Furthermore, miR-9 suppressed not only TM4SF1 expression but also MMP-2, MMP-9 and VEGF expression. In clinical specimens, miR-9 was generally down-regulated in CRC and inversely correlated with TM4SF1 expression. These results suggest that miR-9 functions as a tumor-suppressor in CRC, and that its suppressive effects mediate invasion and metastasis by inhibition of TM4SF1 expression. Our results also indicate that miR-9 might be a novel target for the treatment of CRC invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26983891     DOI: 10.3892/ijo.2016.3430

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  25 in total

1.  MicroRNA-9 rescues hyperglycemia-induced endothelial cell dysfunction and promotes arteriogenesis through downregulating Notch1 signaling.

Authors:  Huang Chen; Zhihai Feng; Lieyou Li; Lin Fan
Journal:  Mol Cell Biochem       Date:  2021-03-15       Impact factor: 3.396

Review 2.  Anti-miRNA oligonucleotides: A comprehensive guide for design.

Authors:  Joana Filipa Lima; Laura Cerqueira; Ceu Figueiredo; Carla Oliveira; Nuno Filipe Azevedo
Journal:  RNA Biol       Date:  2018-03-23       Impact factor: 4.652

3.  MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.

Authors:  Y R Park; S L Kim; M R Lee; S Y Seo; J H Lee; S H Kim; I H Kim; S O Lee; S T Lee; Sang Wook Kim
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-20       Impact factor: 4.553

4.  Identification of six serum antigens and autoantibodies for the detection of early stage epithelial ovarian carcinoma by bioinformatics analysis and liquid chip analysis.

Authors:  Yupeng Zou; Li Li
Journal:  Oncol Lett       Date:  2018-06-26       Impact factor: 2.967

Review 5.  Mutual regulation of microRNAs and DNA methylation in human cancers.

Authors:  Sumei Wang; Wanyin Wu; Francois X Claret
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

6.  Identifying cancer-related microRNAs based on subpathways.

Authors:  Wenbin Liu; Zhendong Cui; Xiangzhen Zan
Journal:  IET Syst Biol       Date:  2018-12       Impact factor: 1.615

7.  Overexpression of miRNA-9 enhances galectin-3 levels in oral cavity cancers.

Authors:  Yunxia Wan; Xi Zhang; Kai Dun Tang; Tony Blick; Liz Kenny; Erik W Thompson; Chamindie Punyadeera
Journal:  Mol Biol Rep       Date:  2021-05-21       Impact factor: 2.316

Review 8.  The Role of MicroRNAs in the Chemopreventive Activity of Sulforaphane from Cruciferous Vegetables.

Authors:  Christopher Dacosta; Yongping Bao
Journal:  Nutrients       Date:  2017-08-19       Impact factor: 5.717

9.  MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7.

Authors:  Lichun Han; Wei Wang; Wei Ding; Lijian Zhang
Journal:  J Cell Mol Med       Date:  2017-03-07       Impact factor: 5.310

10.  miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.

Authors:  Mingxi Zeng; Linlin Zhu; Liangping Li; Changming Kang
Journal:  Cell Mol Biol Lett       Date:  2017-07-17       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.